Wed, October 12, 2016
Tue, October 11, 2016
Mon, October 10, 2016
Fri, October 7, 2016
Thu, October 6, 2016
Wed, October 5, 2016
Tue, October 4, 2016
Mon, October 3, 2016

David Lebovitz Downgraded (ALNY) to Hold on, Oct 7th, 2016


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. itz-downgraded-alny-to-hold-on-oct-7th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


David Lebovitz of Morgan Stanley, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold on, Oct 7th, 2016.

David has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Downgraded from Buy to Hold and Decreased Target to $50 on, Thursday, October 6th, 2016
  • Paul Matteis of "Leerink Swann" Downgraded from Buy to Hold and Decreased Target to $40 on, Thursday, October 6th, 2016
  • Terence Flynn of "Goldman Sachs" Maintained at Hold with Decreased Target to $34 on, Thursday, October 6th, 2016


These are the ratings of the 2 analyists that currently disagree with David


  • Alethia Young of "Credit Suisse" Maintained at Buy with Decreased Target to $50 on, Thursday, October 6th, 2016
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $83 on, Friday, August 5th, 2016

Publication Contributing Sources